Cytospire Therapeutics
Develops multispecific antibodies that engage gamma delta T cells to treat solid tumour cancers.
cytospire.com ↗Why it's here
Raised an oversubscribed £61M ($83M) Series A led by 4BIO Capital in May 2026.
source: cytospire.com- Focus
- Immuno-oncology
- Founded
- 2023
- Latest round
- Series A, £61M, May 2026
- London office
- London Innovation Centre, 20 Water Street, Tower Hamlets E14 5GXsource: cytospire.com
- London presence
- HQsource: cytospire.com
- Investors
- 4BIO Capital (lead), Abingworth, British Business Bank, Criteria Bio Ventures, LifeArc Ventures, Medical Incubator Japan, Modi Ventures, Pathway Bioventures, Servier Ventures, Sound Bioventuressource: cytospire.com
- Area
- Canary Wharf
- Nearest station
- Canary Wharf, 310 m
- Companies House
- CYTOSPIRE THERAPEUTICS LIMITED (14688240, active)Incorporated 24 Feb 2023 · SIC 72110
- Visas
- Licensed visa sponsor, listed as CYTOSPIRE THERAPEUTICS LIMITEDsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix
For Cytospire Therapeutics
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/cytospire-therapeutics"><img src="https://londonmempool.co.uk/badge/cytospire-therapeutics.svg" alt="Cytospire Therapeutics is listed on London Mempool" width="361" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.
Same building
2 more companies on the map list this office address.